46
60
Growth Score 46 in past quarter
-3 pts
Heat Score 60 in past quarter
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Droia Ventures is an early-stage venture capital firm that invests in drug development companies.
- Luc Verelst: Founder & Chairman
- Matthias De Witte: Partner, CFO & General Counsel
About the Company
Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in newly founded or early-stage platform companies that apply novel science and innovative technologies to bring first-in-class drug candidates to patients. With our team of seasoned scientists, entrepreneurs, and
investment professionals we build great companies to save patient lives.
